Sheffield Institute for Translational Neurosciences
Sheffield, S10 2HQ, United Kingdom
NCT Number: NCT02464748
Motor neurone disease (MND) is a rare but debilitating neurological condition that causes paralysis of the body's muscles leading to severe disability and eventually death. Patients often struggle to travel the long distances to specialist clinics to receive the care they require whilst this expert care is often unavailable in the community. Telehealth has the potential to enable a specialist team to monitor the health and wellbeing of patients and their carers whilst they are at home. This could improve the patient's health, improve the quality of life of both patients and their carers, and lead to more effective use of health resources.
This is a randomised controlled pilot study that will involve 40 patients who are cared for by the Sheffield Motor Neurone Disease care centre and their main informal carer (a total of 80 participants). Half of the participants will use the telehealth system for a minimum of six months and maximum of eighteen months and information will be collected from patients, carers and their care team. This will include collecting clinical outcome measures, health resource use and the opinions and experience of using the system. All participants will continue to receive their usual care.
This is a pilot study. It aims to determine the feasibility and acceptability of the telehealth system to patients, carers and their health care providers. It also aims to determine how a larger trial could successfully evaluate the clinical and cost-effectiveness of the system.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Sheffield, S10 2HQ, United Kingdom
MND is often referred to as amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Patient Inclusion Criteria:
o Or
Patient Exclusion Criteria:
Carer inclusion criteria
Carer exclusion criteria
Time frame: Up to 18 months
Recruitment rate, retention rate.
Sheffield Teaching Hospitals NHS Foundation Trust
Other
Telehealth in Motor Neurone Disease: A Single Centre, Randomised Controlled Feasibility and Pilot Study of the Use of the TiM Telehealth System to Deliver Highly Specialised Care in Motor Neurone Disease at a Distance
Acronym: TiM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04695210
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Bedford, United Kingdom
View Trial DetailsNCT02360891
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Angers, France
View Trial DetailsNCT03487263
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Herston, Queensland, Australia
View Trial DetailsNCT06177431
Motor Neuron Disease, Nervous System Diseases
Sydney, New South Wales, Australia
View Trial Details